Transcriptomics the study of structures and functions of transcript molecules. Transcripts comprise all types of ribonucleic acid (RNA) molecules namely, messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding RNA molecules. Increasing approval and new product launch of microarrays is expected to propel growth of the global transcriptomics technologies market over the forecast period. Furthermore, Increasing prevalence of cardiovascular diseases is expected to offer lucrative growth opportunities for players in the global transcriptomics technologies market.
Key features of the study:
- This report provides in-depth analysis of the Global Transcriptomics Technologies market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the Global Transcriptomics Technologies market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Ethicon, Inc. (Johnson & Johnson), Covidien Plc. (Medtronic Plc.), B. Braun Melsungen AG, Medicon EG, Erbe Elektromedizin GmbH, Conmed Corporation, Carefusion, and Cardinal Health.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The Global Transcriptomics Technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Transcriptomics Technologies market
Detailed Segmentation:
- Global Transcriptomics Technologies Market, By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
- Global Transcriptomics Technologies Market, By Application:
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
- Global Transcriptomics Technologies Market, By Region:
- North America
- By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
- By Application
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
- By Country
- Latin America
- By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
- By Application
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
- By Application
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
- By Application
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
- By Application
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
- By Application
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Affymetrix, Inc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd
- Life Technologies Corporation
- LC Sciences, LLC
- Qiagen N.V.
- “*” marked represents similar segmentation in other categories in the respective section.
